Semarion is a spin-out from Cambridge University with a mission to accelerate the pace of drug discovery. We are revolutionising adherent cell screening to produce better data, faster. Our proprietary SemaCyte® cell microcarrier platform leverages novel materials physics to deliver assay flexibility, miniaturisation, and multiplexing with existing tools and workflows. Our microcarriers function as ultra-miniaturized, magnetically steerable wells which can carrier small colonies of cells to enable more powerful assaying workflows and new experimental paradigms.
Company Details
- Employees
- 11
- Founded
- 2018
- Address
- 14 Vawser Way, Cambridge,cambridgeshire Cb2 0ar,united Kingdom
- in****@****ion.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- semarion.com
- HQ
- Cambridge, Cambridgeshire
Semarion Questions
Semarion's website is semarion.com
Semarion's LinkedIn profile is https://uk.linkedin.com/company/semarion
Semarion has
11 employees.
View email and phone details for 11
employees at Semarion.
Semarion's industry is
Biotechnology Research
Semarion's top competitors are
Magnitude Biosciences Ltd,
Constructive Bio,
Abselion,
Spt Labtech,
Maxion Therapeutics,
Elrig,
Insimili,
Oria Bioscience,
Bit.bio,
Qkine.
Semarion's support email address is info@semarion.com
Semarion's categories are Biotechnology Research
Semarion's founding year is 2018
